Related Experiment Video
Updated: Nov 25, 2025
07:35
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
11.7K
[Autosomal dominant polycystic kidney disease : a pediatric perspective]
A Dachy1, L Collard1,2, J M Krzesinski3
1Service de Pédiatrie, CHU Liège, Belgique.
Revue Medicale De Liege
|December 17, 2020
Summary
Polycystic kidney disease (PKD) is a common inherited kidney disorder. Identifying early predictive markers in children is crucial for slowing disease progression and preserving kidney function.
Area of Science:
- Nephrology
- Genetics
- Pediatrics
Background:
- Polycystic kidney disease (PKD) is the most common inherited kidney disease, typically presenting in adulthood.
- Renal cyst development begins in childhood, yet screening protocols for pediatric patients remain undefined.
- Tolvaptan is an approved treatment for slowing PKD progression in adults.
Purpose of the Study:
- To investigate the need for early predictive markers of renal function decline in pediatric patients with PKD.
- To explore potential early indicators for slowing the progression of polycystic kidney disease in children.
Main Methods:
- Review of current scientific literature on PKD progression and pediatric screening.
- Analysis of animal model studies demonstrating the impact of early intervention on cyst growth.
- Examination of the efficacy of tolvaptan in adult PKD patients.
Main Results:
- PKD cyst formation starts early in life, suggesting a window for intervention.
- Animal models indicate that inhibiting cyst growth can decelerate renal function decline.
- Current adult treatments like tolvaptan highlight the potential for therapeutic strategies in slowing PKD.
Conclusions:
- Early identification of predictive markers in children is essential for proactive PKD management.
- Developing pediatric screening strategies could significantly impact long-term renal health outcomes.
- Further research is warranted to establish consensus on pediatric PKD screening and early intervention.
More Related Videos
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
362
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
362
01:10Nephrons
5.2K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
5.2K
01:28Chronic Kidney Disease III: Interprofessional Care
213
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
213
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
110
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
110
01:24Renal Tubule and Collecting Duct
2.5K
The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
2.5K
01:24Nephrotic Syndrome I : Introduction
281
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
281